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Abstract
Metabolic Syndrome (MetS) is associated with increased risk of morbi-mortality, thus the characterization of the
population magnitude of this syndrome is critical for allocating health care. However, prevalence estimates of MetS
in the same population could differ depending on the definition used. Therefore, we compared the prevalence of
the MetS using definitions proposed by: National Cholesterol Education Panel Revised (NCEP) and International
Diabetes Federation (IDF) 2009 in a Japanese-Brazilians community (131 individuals, age 57 ± 16 years, 1st and 2nd
generation). All individuals went through a clinical and laboratorial evaluation for assessment of weigh, height,
waist circumference, blood pressure, triglycerides, HDL-cholesterol and fasting plasma glucose. The prevalence of
MetS was 26.7% (n = 35) and 37.4% (n = 49) under the NCEP and IDF definitions, respectively. Despite higher blood
pressure measurements, waist circumference and serum triglyceride levels and lower HDL cholesterol levels
(p < 0.01), individuals identified with MetS did not show increased blood glucose levels. IDF definition classified 14
individuals (10.7%) with MetS that were not classified under the NCEP and 35 individuals were identified with MetS
by both criteria. We observed, in this group, more severe lipid disorders, compared to individuals identified only
under the IDF definition, and the BMI and waist circumference (p = 0.01; p = 0.006, respectively) were lower. In
conclusion, the IDF revised criteria, probably because of the ethnic specific values of waist circumference, was able
to identify a larger number of individuals with MetS. However, our data suggesting that additional studies are
necessary to define best MetS diagnostic criteria in this population.
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Introduction
The metabolic syndrome (MetS) is an aggregation of
biochemical and physical conditions that presage the de-
velopment of atherosclerotic cardiovascular disease. Al-
though it has been known for more than 80 years, the
clustering received scant attention until 1988 when
Reaven described syndrome X [1]. Further, other me-
tabolic abnormalities have been considered as part of
the syndrome, like abnormal weight or weight distribu-
tion, inflammation, microalbuminuria, hyperuricemia,
and abnormalities of fibrinolysis and coagulation [2]. The
constellation of metabolic abnormalities of the MetS
includes glucose intolerance, insulin resistance, central
obesity, dyslipidaemia and hypertension, all well docu-
mented risk factors for cardiovascular disease.
People with the MetS are at increased risk of all-cause
and cardiovascular disease (CVD) mortality [3-5]. In ad-
dition, components of the MetS are risk factors for dia-
betes [6]. Over the last decade several clinical criteria for
MetS have been developed [7,8]. Clinically defined MetS
criteria were proposed by the National Cholesterol Educa-
tion Program (NCEP) (The Expert Panel on Detection,
Evaluation, and Treatment of High Blood Cholesterol in
Adults: Executive summary of the third report of the
National Cholesterol Education Program (NCEP) Expert
Panel on Detection, Evaluation, and Treatment of High
Blood Cholesterol in Adults, 2001) [9] and were subse-
quently revised (NCEP-R) by lowering the threshold for
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blood glucose to correspond to the impaired fasting glu-
cose cutoff of the American Diabetes Association [10].
Most recently, the International Diabetes Federation (IDF)
proposed consensus criteria for identification of MetS
[11].
MetS is associated with increased risk of cardiovascu-
lar morbi-mortality, thus understanding the dimension
of this syndrome is critical for allocating health care and
research resources. However, by the use of different defi-
nitions, prevalence estimates of MetS in the same popu-
lation could differ depending on the definition used. In
Mumbuca/Guatapara, located in Sao Paulo state, Brazil,
there is a population that migrated from Japan in 1962,
that lives as a semi-rural community and has retained
much of their traditional habits. Thus the propose of this
study was to compare the prevalence of the MetS using
definitions proposed by: NCEP and IDF definitions in a
Japanese-Brazilians community.
Subjects and methods
This study was a cross-sectional evaluation of a Japanese-
Brazilians Community in Mumbuca/Guatapara, Sao Paulo
State. We evaluated 131 individuals from first and second
generations, what represents 66.8% of the adults older
than 20 years of this community. Individuals not Japanese
descendent or younger than 20 years, were not included
in the study. The patients comprised 54 (41.2%) men and
77 (58.8%) women with a mean age of 57 ± 16 years.
Clinical and laboratorial evaluations were performed by
trained professionals with adequate equipment. The Ethics
Committee of the University Hospital of the School of
Medicine of Ribeirão Preto-USP approved the study
protocol and all participants gave written informed con-
sent to participate in the study.
Clinical examination
All participants underwent a clinical examination after
fasting for at least 12 h. Anthropometric evaluation was
performed with the participant barefoot and wearing
light clothing. The weight in kilogram was assessed in
an electronic scale (FilizolaW) and the height, in cen-
timeters, was measured with a portable stadiometer. The
body mass index (BMI) was calculated by dividing
weight (kg) by height (m) squared. Patients were cate-
gorized according to BMI values advocated by the Inter-
national Obesity Task Force (IOTF) for the Asian
population: between 23 and 24.9 kg/m2 for overweight
and ≥ 25 kg/m2 for obesity [12].
Waist circumference was measured midway between
the lower edge of the last rib and the iliac crest, to ac-
cess the abdominal obesity (AO). To check the blood
pressure (BP), we used an automated device (OMRONW,
Itapevi, SP Brazil) with appropriate cuff. The normal
values of BP were those recommended by the VI Brazilian
Guidelines for Hypertension (2010) [13], and was consi-
dered the final blood pressure, the mean of the last two of
three consecutive measurements. All instruments were
checked for calibration before using.
A fasting blood sample was obtained, and concen-
trations of triglycerides, HDL cholesterol, basal insulin
and glucose were assayed using automated techniques.
For measures of triglycerides (TG) and HDL-cholesterol
(HDL-C) we used an automated spectrophotometric me-
thod (Wiener lab, Rosario, Argentina). Glucose was mea-
sured by enzymatic method (hexokinase).
Metabolic syndrome
According to NCEP definition, MetS is present if three
or more of the following are present: high waist circum-
ference (> 102 cm for males and > 88 cm for females),
high triglyceride levels (≥ 150 mg/dL), low HDL cho-
lesterol levels (< 40 mg/dL for men and < 50 mg/dL for
women), elevated blood pressure (≥ 130/85 mmHg) and
elevated glucose values (≥ 100 mg/dL). According to IDF
definition, MetS is present if there is present three or
more of the following: high waist circumference (≥ 90 cm
for men and ≥ 80 cm for women, in the Japanese group),
high triglyceride level, low HDL cholesterol level, elevated
blood pressure and elevated glucose value. In addition to
the clinical criteria, individuals who reported use of anti-
hypertensive or antidiabetic agents were classified as ha-
ving elevated blood pressure and glucose, respectively, for
both MetS definitions.
Statistical analysis
According to the NCEP and IDF definitions the indivi-
duals studied were divided in two groups. Individuals
identified by both definitions were classified as concord-
ant group and individuals identified with MetS only by
the IDF definition were classified as discordant group.
After testing for normal distribution, an ANOVA statis-
tic test was used to analyze the relation between each
variable involved in the MetS classification according
to the two different definitions used. The Kappa Coef-
ficient of Agreement was determined to evaluate the con-
cordance between the two definitions. A significance
level of 0.05 (α = 5%) was adopted, and levels below
this were considered significant. All analyses were con-
ducted using SAS software, version 9.1 (SAS Institute,
Cary, NC).
Results
Analyzing the 131 patients we observed that 37.4%
(n = 49) of the individuals studied were classified as ha-
ving MetS. Although, the prevalence of MetS was 26.7%
(n = 35) and 37.4% (n = 49) under the NCEP and IDF
definitions, respectively (Figure 1). Individuals identified
with MetS showed higher blood pressure measurements,
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waist circumference, elevated serum triglyceride levels
and lower HDL cholesterol levels (p < 0.01, Table 1), as
expected, however they did not show significant higher
fasting plasma glucose levels. All individuals identified
under the NCEP definitions were also identified under
the IDF. The two definitions showed a high concordance
according to the Kappa coefficient (0.76, confidence
interval: 0.64; 0.87).
Among all participants, IDF definition classified 14
(10.7%) individuals with MetS that were not classified
under the NCEP (discordant) and 35 individuals were
identified with MetS with both criteria (concordant). We
observed, in the last group, higher triglycerides and
lower HDL (p < 0.01) and higher fasting plasma glucose
(p = 0.05) compared to individuals identified only under
the IDF definition. Interestingly the BMI and waist cir-
cumference (p = 0.01; p = 0.006, respectively) were lower
in the concordant compared to discordant groups. How-
ever, there was no difference among the groups accor-
ding to age, total cholesterol, LDL cholesterol, and blood
pressure levels.
Individuals identified with MetS were mostly female
(36.3%). In addition, individuals with MetS independent
of the diagnostic criteria, showed increased levels of tri-
glycerides compared to the discordant group (p = 0.004)
and increased values of BMI (p = 0.02) and waist circum-
ference (p = 0.007) compared to the concordant group.
Discussion
In this study we have provided the first assessment of
the prevalence of MetS, in the Japanese-Brazilian com-
munity of Mumbuca/Guatapara, using the recently revised
IDF criteria [11]. We also compared it to the prevalence
using the more traditional NCEP definition. Besides, both
IDF and NCEP focus specifically on waist circumference,
which is a surrogate measure of central obesity, the IDF
definition builds upon the NCEP criteria, but differs in
two key aspects. First, the IDF has lowered the threshold
for waist circumference from 102 to 94 cm. Second, waist
circumference is different according to ethnical characte-
ristics. Previous studies have shown that using a lower
waist circumference threshold within the context of MetS
increases the prevalence, but decreases the risk of morta-
lity [3] and type 2 diabetes [14].
Previous studies have observed an increased preva-
lence of MetS among American-Japanese compared to
native Japanese, demonstrating the influence of the
westernization of the lifestyle [15]. Data like this has
raised interest in assessing the prevalence of MetS in
Japanese migrant populations. Mumbuca/Guatapara, lo-
cated in Sao Paulo state, Brazil, becomes an interesting
population to study the effect of the western lifestyle
in Japanese communities, since they represents the last
Japanese migration to Brazil and living as a semi-rural
community they retained much of their traditional habits.
Several studies have reported the difference in MetS
prevalence estimates depending on the definition used
[16-18]. However, there is a tendency to define diagnos-
tic criteria based on ethnicity and central obesity [19].
The American Heart Association/National Heart, Lung,
and Blood Institute, had, already, recommended different
values to Asian population [10], and in a recent study in
a Japanese-Brazilian community it was observed that the
MetS prevalence was higher using the NCEP criteria for
Asians [20]. We believe that our data reinforce this idea,
since the IDF criteria showed the higher MetS preva-
lence compared to the NCEP definition.
In addition, we demonstrate that individuals with MetS
had significant lipid disorders, higher prevalence of central
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Figure 1 Prevalence (%) of individuals with metabolic
syndrome according to the IDF 2009 and NCEP criteria.
Table 1 Clinical and laboratory characteristics of the population according to the four different groups
Fasting plasma
glucose (mg/dL)
HDL cholesterol
(mg/dL)
Triglyceride
(mg/dL)
BMI
(kg/m2)
Waist
circumference (cm)
Sistolic
blood pressure
(mmHg)
Diastolic
blood pressure
(mmHg)
Total 92.6 ± 19.5 49.4 ± 13.2 145.1 ± 87.0 24.7 ± 4.0 84.4 ± 10.5 135.0 ± 25.5 79.0 ± 12.6
NCEP 99.6 ± 15.3 41.2 ± 9.8 212.6 ± 80.1 27.3 ± 4.5 93.0 ± 11.7 149.8 ± 29.6 85.2 ± 15.3
IDF 97,5 ± 14.6 42.9 ± 9.4 188.4 ± 81.0** 26.8 ± 4.27* 91.5 ± 10.7* 148.3 ± 27.3 85.2 ± 13.5
Discordant 91.8 ± 11.8# 47.7 ± 6.5# 119.8 ± 32.8# 25.1 ± 2.93# 87.5 ± 6.8# 146.2 ± 21.3 85.4 ± 8.5
Concordant 106.0 ± 19.5 43.0 ± 10.6 213.9 ± 83.4 22.5 ± 2.96 78.9 ± 6.5 138.2 ± 9.7 80.7 ± 15.6
*p < 0.05 comparing IDF and group Concordant; **p < 0.05 comparing IDF and group Discordant #p < 0.05 comparing group Concordant and group Discordant.
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obesity and elevated blood pressure levels, which are well
known cardiovascular disease risk factors, but not higher
fasting plasma glucose levels. Interestingly, concordant
group, composed by those identified with MetS by both
criteria, did present higher glucose and lipid levels, but
lower BMI and waist circumference values. Therefore, our
data highlight the importance of insulin resistance in the
etiology of MetS in Japanese-Brazilians [21]. The World
Health Organization (WHO) and European Group for the
study of Insulin Resistance (EGIR) had proposed diagnos-
tic criteria based on the detection of insulin resistance. In
fact, it had been demonstrated that the WHO criteria
detects more individuals with MetS, having more glucose
metabolism and lipid disorders, compared to NCEP cri-
teria [22]. Besides, the same study, recommends the use of
NCEP criteria with reduced waist cutoff for the MetS de-
tection, based in its practicability.
In conclusion, the high prevalence of MetS shows that
Japanese-Brazilian community of Mumbuca is in increa-
sed risk for cardiovascular disease. According to the in-
creased deterioration of the glucose and lipid metabolism,
associated with central obesity, individuals identified with
MetS would benefit most from lifestyle adjustment. The
IDF revised criteria, because of the ethnic specific values
of waist circumference, was able to identify a larger num-
ber of individuals with MetS.
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